493 related articles for article (PubMed ID: 32899427)
1. Radioresistance in Glioblastoma and the Development of Radiosensitizers.
Ali MY; Oliva CR; Noman ASM; Allen BG; Goswami PC; Zakharia Y; Monga V; Spitz DR; Buatti JM; Griguer CE
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899427
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome c oxidase mediates labile iron level and radioresistance in glioblastoma.
Ali MY; Oliva CR; Flor S; Goswami PC; Griguer CE
Free Radic Biol Med; 2022 May; 185():25-35. PubMed ID: 35476930
[TBL] [Abstract][Full Text] [Related]
3. Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma.
Matsui JK; Perlow HK; Ritter AR; Upadhyay R; Raval RR; Thomas EM; Beyer SJ; Pillainayagam C; Goranovich J; Ong S; Giglio P; Palmer JD
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885067
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Radioresponse and Radiosensitizers in Glioblastoma Organotypic Cultures.
Bayin NS; Ma L; Placantonakis DG; Barcellos-Hoff MH
Methods Mol Biol; 2018; 1741():171-182. PubMed ID: 29392699
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
Li R; Wang H; Liang Q; Chen L; Ren J
Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
[TBL] [Abstract][Full Text] [Related]
6. Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model.
Doan NB; Nguyen HS; Alhajala HS; Jaber B; Al-Gizawiy MM; Ahn EE; Mueller WM; Chitambar CR; Mirza SP; Schmainda KM
Oncotarget; 2018 May; 9(34):23532-23542. PubMed ID: 29805753
[TBL] [Abstract][Full Text] [Related]
7. Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance.
Nguyen HS; Shabani S; Awad AJ; Kaushal M; Doan N
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899215
[TBL] [Abstract][Full Text] [Related]
8. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma.
Shin E; Kim B; Kang H; Lee H; Park J; Kang J; Park E; Jo S; Kim HY; Lee JS; Lee JM; Youn H; Youn B
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127511. PubMed ID: 37866557
[TBL] [Abstract][Full Text] [Related]
10. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
11. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
[TBL] [Abstract][Full Text] [Related]
12. SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes.
Zeng L; Zheng W; Liu X; Zhou Y; Jin X; Xiao Y; Bai Y; Pan Y; Zhang J; Shao C
Theranostics; 2023; 13(11):3725-3743. PubMed ID: 37441590
[No Abstract] [Full Text] [Related]
13. AHIF promotes glioblastoma progression and radioresistance via exosomes.
Dai X; Liao K; Zhuang Z; Chen B; Zhou Z; Zhou S; Lin G; Zhang F; Lin Y; Miao Y; Li Z; Huang R; Qiu Y; Lin R
Int J Oncol; 2019 Jan; 54(1):261-270. PubMed ID: 30387845
[TBL] [Abstract][Full Text] [Related]
14. HSP90B1-mediated plasma membrane localization of GLUT1 promotes radioresistance of glioblastomas.
Li Y; Ge Y; Zhao M; Ding F; Wang X; Shi Z; Ge X; Wang X; Qian X
J Biomed Res; 2023 Sep; 37(5):326-339. PubMed ID: 37750323
[TBL] [Abstract][Full Text] [Related]
15. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
[TBL] [Abstract][Full Text] [Related]
16. GBM radiosensitizers: dead in the water…or just the beginning?
Bindra RS; Chalmers AJ; Evans S; Dewhirst M
J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
[TBL] [Abstract][Full Text] [Related]
17. Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy
Alhajala HS; Nguyen HS; Shabani S; Best B; Kaushal M; Al-Gizawiy MM; Erin Ahn EY; Knipstein JA; Mirza S; Schmainda KM; Chitambar CR; Doan NB
Oncotarget; 2018 Sep; 9(75):34122-34131. PubMed ID: 30344926
[TBL] [Abstract][Full Text] [Related]
18. DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma.
Kang H; Lee H; Kim K; Shin E; Kim B; Kang J; Kim B; Lee JS; Lee JM; Youn H; Youn B
Cell Rep Med; 2023 Jan; 4(1):100880. PubMed ID: 36603576
[TBL] [Abstract][Full Text] [Related]
19. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
[TBL] [Abstract][Full Text] [Related]
20. miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells.
Xiao S; Yang Z; Lv R; Zhao J; Wu M; Liao Y; Liu Q
PLoS One; 2014; 9(9):e108810. PubMed ID: 25265336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
